The Challenge of Highly Pathogenic Microorganisms (Record no. 113579)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05506nam a22005295i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-90-481-9054-6 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220084602.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 100623s2010 ne | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9789048190546 |
| -- | 978-90-481-9054-6 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-90-481-9054-6 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | QR46 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MMFM |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED052000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.9041 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Shafferman, Avigdor. |
| Relator term | editor. |
| 245 14 - TITLE STATEMENT | |
| Title | The Challenge of Highly Pathogenic Microorganisms |
| Medium | [electronic resource] : |
| Remainder of title | Mechanisms of Virulence and Novel Medical Countermeasures / |
| Statement of responsibility, etc | edited by Avigdor Shafferman, Arie Ordentlich, Baruch Velan. |
| 264 #1 - | |
| -- | Dordrecht : |
| -- | Springer Netherlands : |
| -- | Imprint: Springer, |
| -- | 2010. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XVIII, 314p. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | The Anthrax Capsule: Role in Pathogenesis and Target for Vaccines and Therapeutics -- Proteomic Studies of Bacillus anthracis Reveal In Vitro CO2-Modulation and Expression During Infection of Extracellular Proteases -- Dynamics of Bacillus anthracis Infection and Control Mechanisms -- Survival and Trafficking of Yersinia pestis in Non-acidified Phagosomes in Murine Macrophages -- The Inverse Relationship Between Cytotoxicity of Y. pestis and Its Virulence -- The NlpD Lipoprotein of Yersinia pestis is Essential for Cell Separation and Virulence -- Dissection of the Functions of the IglC Protein of Francisella tularensis -- Yersinia pestis Lipopolysaccharide in Host-Pathogen Interactions -- The Interactions Between Pathogens and Dendritic Cells: From Paralysis of Cells to Their Recruitment for Bacterial Colonization -- Comparative Approaches to Identify Host Factors Specifically Targeted by Yersinia pestis During the Infectious Process -- Poxvirus Entry into Host Cells -- Role of A33R Amino-Acid 118L in the Interactions of Vaccinia Virus with the Host -- Inhibitors of Innate Immunity from Vaccinia Virus -- Brucella Species Synchronize Their Life Cycle to the Gestation Cycle of Their Ruminant Hosts -- MMP-9 as a Marker for Vaccinia Virus Related Encephalitis -- Epidemic Cowpox Virus Infections in Germany -- The Two Partner SecretionTwo Partner Secretion Transporters of Yersinia pestis: Cloning, Immunogenicity and In Vivo Expression Following Airway Infection -- Genetic Detection of Vesicle Forming Pathogens by Arrayed Primer Extension (APEX) -- Subtyping Biothreat Bacterial Pathogens -- A Rapid Method for Bacillus anthracis Genotyping -- Tularemia – A Disease with an Uncertain Impact on Public Health -- Consequences of Antibiotic Treatment of Francisella tularensis Airways Infections -- Novel Live Vaccine Candidates Against Airborne Francisella tularensis -- Effect of Disruption of mglA on the Virulence and Immunogenicity of the Francisella tularensis Live Vaccine Strain (LVS) -- Data Mining, Bioinformatic and Immunoinformatic Analyses of Francisella tularensis Schu S4 Genome in Search for Novel Vaccine Candidates -- Modified Vaccinia Virus Ankara (MVA) based Vaccines – Immunostimulatory and Protective Capacity -- Therapeutic Potential of Vaccinia Hyper Immune Sera in Mouse Models of Lethal Orthopoxviruses Infection -- A Live Plaque Vaccine Candidate with Improved Safety and Immunogenecity -- Protection Against Plague Afforded by Treatment with Polyclonal ?LcrV and ?F1 Antibodies -- Combination of Anthrax-Toxin Neutralizing Antibodies: Analysis of Synergism/Antagonism Effect -- The Efficacy of Antibiotic Treatment to Cure Guinea Pigs Intranasally Infected with Bacillus anthracis Spores -- Reverse Vaccinology in Bacillus anthracis Bacillus anthracis . |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | This book addresses the unique features of four microorganisms that constitute the top bioterror threat agents: Bacillus anthracis; Yersinia pestis, Francisella tularensis and Orthopoxviruses. Side-by-side updated information about their pathogenisis, virulence and epidemiology is provided in a single volume, allowing for evaluation of common features as well as common strategies for defense. Classical microbiological as well as genomic, proteomic & transcriptomic approaches towards development of strategies of novel prophylactic and post-exposure treatment and related aspects of diagnostics and bioforensics are covered. Written by top scientists, this book will be of major interest to all researchers interested in the intricate biology of highly pathogenic microorganisms, to scientists and clinicians interested in microbial pathogenesis and prevention, and to a wide range of professionals dealing with the various aspects of bio-defense. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Microbiology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Vaccines. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Bacteriology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Microbial genetics. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biomedicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medical Microbiology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Microbiology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Vaccine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Bacteriology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Eukaryotic Microbiology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Microbial Genetics and Genomics. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ordentlich, Arie. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Velan, Baruch. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9789048190539 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-90-481-9054-6 |
| 912 ## - | |
| -- | ZDB-2-SBL |
No items available.